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Lymph node (LN) is a secondary lymphoid organ with highly organized and compart-
mentalized structure. LNs harbor B, T, and other cells among fibroblastic reticular cells
(FRCs). FRCs are characterized by both podoplanin (PDPN/gp38) expression and by
the lack of CD31 expression. FRCs are involved in several immune response processes 
but mechanisms underlying their function are still under investigation. Double-negative
cells (DNCs), another cell population within LNs, are even less understood. They do not 
express PDPN or CD31, their localization within the LN is unknown, and their phenotype 
and function remain to be elucidated. This study evaluates the gene expression and cyto-
kines and chemokines profile of human LN-derived FRCs and DNCs during homeostasis 
and following inflammatory stimuli. Cytokines and chemokines secreted by human FRCs 
and DNCs partially diverged from those identified in murine models that used similar
stimulation. Cytokine and chemokine secretion and their receptors expression levels
differed between stimulated DNCs and FRCs, with FRCs expressing a broader range
of chemokines. Additionally, dendritic cells demonstrated increased migration toward
FRCs, possibly due to chemokine-induced chemotaxis since migration was significantly 
decreased upon neutralization of secreted CCL2 and CCL20. Our study contributes to 
the understanding of the biology and functions of FRCs and DNCs and, accordingly, of 
the mechanisms involving them in immune cells activation and migration.
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inTrODUcTiOn
The immunological function of lymph nodes (LNs) includes the 
initiation of antigen-specific immune responses as well as the 
induction of tolerance when required. These secondary lymphoid 
organs possess a structured morphology and harbor a variety of 
cell populations, including lymphocytes B, T, and other less char-
acterized cell populations. Among these, the fibroblastic reticular 
cells (FRCs) are phenotypically characterized by both podoplanin 
expression (PDPN, gp38) and by the absence of CD31 expression 
(1–3). FRCs are known to participate in several immune response 
processes, including immune cells homing and activation, but 
essential mechanisms fundamental to these functions are still 
under investigation (2, 4). The double-negative cells (DNCs) 
constitute a poorly understood cell population within LNs. These 
cells do not express gp38 or CD31, their localization within LNs is 
unclear, and their function remains to be elucidated (5–7).
Fibroblastic reticular cells and DNCs share stromal cells 
phenotype and are known to secrete chemokines (8). They are 
involved in the control of migratory patterns and positioning of 
immune cells during homeostasis or inflammatory response (8). 
In animal models, FRCs and DNCs react to inflammatory stimuli 
such as interleukin 1 (IL-1), interferon (IFN)-α, -β, and -γ, and 
tumor necrosis factor (TNF)-α, by altering chemokines gene and 
protein expression profiles (9–12). Chemokines constitute a large 
family of small cytokines involved in immune cells chemotaxis. 
Some chemokines are considered pro-inflammatory and released 
upon infection, while others are considered homeostatic and 
involved in the control of cell migration during tissue develop-
ment or maintenance. The physiologic importance of this family 
of mediators results from their specificity because its members 
induce recruitment of well-defined leukocyte subsets (13, 14).
Chemokines are secreted by FRCs within LNs where they 
orchestrate the encounter between diverse immune cell types. 
In murine LNs, FRCs are localized in the paracortex and they 
produce CCL19 and CCL21, attracting T and dendritic cells 
via CCR7 (5). IL-7 secretion is also attributed to FRCs (2). IL-7 
contributes to the maintenance of naïve T cells survival and IL-7 
signaling is regulated by IL-7Rα, a specific receptor, in FRCs (2, 
15). Other studies in murine models and humans reported FRCs 
also producing IL-6 and IL-15 (5, 8, 16).
Our study evaluates the expression of interleukins and 
chemokines in human-derived FRCs and DNCs under standard 
culture conditions and following inflammatory stimuli using 
IFN-γ and TNF-α + IL-1β treatment. IFN-γ induces lymphocytes 
differentiation and is produced by several immune cell subtypes 
in response to inflammatory stimulation (17). In contrast, the 
cytokine TNF-α is secreted by T and B cells in response to antigenic 
stimulation (18), while IL-1β takes part in several immunologic 
processes, including T cells differentiation into Th1 and Th2 (10).
We demonstrate that, following inflammatory stimulation, the 
secretion of interleukins and chemokines by human LN-derived 
FRCs and DNCs partially differed from those identified in 
murine models. In addition, FRCs showed a broader range of 
chemokines being upregulated when compared with DNCs. 
These results suggest that distinct immune cells subsets may 
interact with either FRCs or DNCs. Accordingly, dendritic cells 
demonstrated an increased migration potential toward FRCs fol-
lowing treatment with TNF-α and IL-1β and their migration was 
significantly decreased upon neutralization of secreted CCL2 or 
CCL20. These results imply functional differences between FRCs 
and DNCs within LNs.
MaTerials anD MeThODs
human lns
Peripheral or mesenteric human LNs were obtained from four 
individuals with different ages and clinical status (larynx cancer—
LN03, diverticulitis—LN12, breast cancer—LN15 patients, and 
an organ donor for liver transplantation—LN16) submitted to 
surgical procedures. All research participants signed an informed 
consent (approved by Hospital Israelita Albert Einstein research 
ethics committee under CAAE number: 07768712.4.0000.0071). 
All LNs were submitted to histopathological examination, which 
confirmed that they were not visually affected by the disease.
histopathology and 
immunohistochemistry
Formalin-fixed paraffin-embedded LN samples were sectioned 
into 3 µm thick slices and transferred to microscope slides. The 
slides containing the tissue were stained with hematoxylin–eosin 
(HE). Immunohistochemical staining was performed using 
Autostainer DAKO automated immunohistochemistry slide 
processing platform according to the manufacturer’s instructions 
and individual staining was performed for CD20 (clone: L26), 
CD3 (Polyclonal), and CD68 (clone: PGM-1) antibodies, all from 
Dako (Glostrup, Denmark). Histopathology and immunohisto-
chemistry were performed by the Clinical Pathology Laboratory 
from Hospital Israelita Albert Einstein.
enzymatic Digestion of lns
For the isolation of the stromal cells, the LN was shredded with 
a scalpel. Lymphocytes released in the media were collected and 
frozen for further analysis and the remaining of the lymphoid tis-
sue was washed with Hank’s balanced salt solution (HBSS, Gibco, 
Carlsbad, CA, USA) and incubated at 37°C for 30 min in 9 mL 
of HBSS, 1 mL of Accutase (Innovative Cell Technologies, San 
Diego, CA, USA), 0.6 ng/mL of collagenase type II, and 1 µL of 
turbo DNAse (Invitrogen, Carlsbad, CA, USA). The tube contain-
ing the tissue underwent mechanical stirring every 5 min during 
the 30-min incubation period. After incubation, the LN frag-
ments were vigorously stirred with a needle to complete the tissue 
disruption. Samples were then centrifuged (500 g, 5 min, 22°C), 
and the pelleted cells were suspended in DMEM-LG and cultured 
(5% CO2, 37°C) in 25 cm2 culture flasks. After the third passage, 
the plastic adherent cells were phenotypically characterized and 
sorted in two cell populations, FRCs and DNCs, according to the 
procedures described in the following section.
Frcs and Dncs immunophenotyping and 
sorting by Flow cytometry
Immunophenotyping of cells was performed with the following 
antibodies: CD34-PE (clone: 8G12) from BD Biosciences, San 
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Jose, CA, USA; CD14-Alexa 700 (clone: M5E2), CD29-APC 
(clone: MAR04), CD35-FITC (clone: E11), CD44-PerCP-Cy5.5 
(clone: G44-26), CD73-PE (clone: AD2), CD90-PE-Cy7 
(clone: 5E10), HLA-DR-APC-H7 (clone: G46-6), CD106-FITC 
(clone: 51-10C9) all from BD Pharmingen, San Diego, CA, 
USA; CD31-V450 (clone: WM59), CD45-V500 (clone: H130), 
CD105-PE-CF546 (clone: 266) all from BD Horizon, San 
Jose, CA, USA, and gp38/PDPN-APC (polyclonal) from R&D 
Systems, Minneapolis, MN, USA, and fluorescence minus one 
(FMO) was used as a fluorescence background control. Briefly, 
1  ×  105 cells were incubated in the dark/room temperature 
for 30  min in the presence of antibodies at concentrations 
recommended by the manufacturers. Cells were then washed 
with buffered solution and at least 10,000 events were acquired 
using FACS LSRII FORTESSA (BD Biosciences). Cell popula-
tions were characterized according to the following reference 
markers: FRCs: gp38+, CD31−; DNCs: gp38−, CD31−; 
lymphatic endothelial cells: gp38+, CD31+; blood endothelial 
cells: gp38−, CD31+ and/or CD106+; follicular dendritic cells 
(FDCs): gp38+, CD35+; hematopoietic cells: CD45+, CD14+ 
or CD34+; stromal cells markers: CD29, CD44, CD73, CD90, 
and CD105. Data were analyzed using the FACSDIVA (BD 
Biosciences) and/or the FlowJo software (Tree Star, Ashland, 
OR, USA).
After characterization, cells were sorted according to gp38/
PDPN expression: gp38/PDPN positive, the FRCs, and gp38/
PDPN negative, the DNCs, using FACSARIA II cell sorting (BD 
Biosciences). Cell sorting was performed in order to achieve high 
cell population purity (>95%). After cell sorting and expansion in 
culture, an additional step of gp38/PDPN expression verification 
was performed before every experiment; if purity was below 95% 
cells were resorted, as described in Figure S1 in Supplementary 
Material.
Differentiation of cells into adipocyte-, 
chondrocyte-, and Osteocyte-like cells
In order to evaluate FRCs and DNCs stromal cell characteristics, 
we studied their differentiation potential. Both cell subtypes 
were cultured in specific differentiation media for 21  days 
following literature guidelines (19, 20). For adipogenic differ-
entiation, the medium used was Alpha-MEM (Gibco) supple-
mented with 10% FBS (Gibco), 1 µM dexamethasone, 100 µg/
mL 3-isobutyl-1-methylxanthine IBMX, 10 µg/mL insulin, and 
100 µM indomethacin (all from Sigma, St. Louis, MO, USA). 
The osteogenic differentiation medium used was Alpha-MEM 
supplemented with 10% FBS, 1  µm dexamethasone, 2  µg/mL 
ascorbic acid, and 10 µM β-glycerophosphate (all from Sigma 
St. Louis, MO, USA). For chondrogenic lineage differentiation, 
we used the medium Alpha-MEM supplemented with 10% FBS, 
1 µm dexamethasone, 2 µg/mL ascorbic acid and 6.25 µg/mL 
insulin from Sigma, and 10 ng/mL TGF-β from R&D Systems. 
After 21  days, cells were fixed and stained with specific dyes 
to confirm differentiation: the adipogenic cultures were fixed 
in 4% paraformaldehyde and stained with oil red (Sigma) to 
indicate the lipid droplets formation inside the cells; cells in 
osteogenic culture were fixed in 50% ethanol at 4°C and stained 
with Alizarin Red (Sigma) to indicate the calcium deposition 
in the culture, and the chondrogenic cultures were fixed in 
crescent ethanol concentrations (70, 90, and 100%) and stained 
with toluidine blue (Sigma) to identify the proteoglycan-rich 
matrix.
Dendritic cells Differentiation and 
Maturation
Monocytes were derived from peripheral blood obtained from 
four healthy volunteers after they signed an informed consent. 
Peripheral blood cells were diluted 1:3 with phosphate-buffered 
saline. The suspension was transferred to a 15-mL conical tube 
containing 5 mL of Ficoll-Paque 1.077 density (GE Healthcare, 
UK) and centrifuged (30  min/500  g) at 22°C. The cells from 
the interface were collected, ressuspended, and centrifuged 
again (5  min/500  g). Cells were then separated according to 
CD14 expression using a magnetic selection column (Miltenyi 
Biotec, Bergisch Gladbach, Germany). The CD14 cell popula-
tion was dispensed into six-well plates containing X-vivo 15 
medium (Cambrex) supplemented with antibiotic-antimycotic 
solution (Gibco). To generate immature dendritic cells (iDCs), 
the cells were cultured in the presence of human recombinant 
IL-4 (20  ng/mL) and GM-CSF (50  ng/mL) (both from R&D 
Systems, Minneapolis, MN, USA) for 6 days (20). Mature DCs 
were obtained after iDC stimulation with LPS 100 ng/mL for 24 h 
(Sigma-Aldrich). Monocytes and monocyte-derived immature 
and mature DCs were analyzed for chemokines receptor as 
described in the following section.
lymphocytes isolation
Lymphocytes were isolated from peripheral blood obtained from 
11 healthy volunteers after they signed an informed consent. An 
aliquot of whole blood cells was immediately stained for lympho-
cyte-specific markers and chemokines receptors as described in 
the following section. Lymphocytes were also isolated from the 
LNs as described in the Section “Enzymatic Digestion of LNs.” 
LN-derived lymphocytes (n = 6) were also stained for lympho-
cyte-specific markers and chemokines receptors as described in 
the following section. The chemokine receptors expression of the 
peripheral blood lymphocytes and the LN-derived lymphocytes 
were compared.
Dendritic cells and lymphocytes 
chemokine receptors Detection by Flow 
cytometry
Immunophenotyping of lymphocytes, monocytes, and mono-
cyte-derived DCs was performed with the following antibodies: 
CD3-PerCP-Cy5.5 (clone: SK7), CD33-APC (clone: P67.6), and 
HLA-DR-PerCP-Cy5.5 (clone: G46.6), from BD Biosciences, 
CD209-FITC (clone: DCN46), CD8-APC-Cy7 (clone: SK1), 
CD80-PE (clone: L307.4), CD86-PE (clone: 2331-FUN-1), 
CCR7-FITC (clone: 3D12), CD14-PerCP-Cy5.5 (clone: M5E2), 
CD4-Alexa-700 (clone: RPA-T4), CXCR4-PE (clone: 12G5), 
CCR2-Alexa-647 (clone: 48607), CCR6-PE-Cy7 (clone: 11A9) 
from BD Pharmingen, CCR3-BV421 (clone: 5E8), CCR5-
PE-CF594 (clone: 2D7/CCR5) from BD Horizon. FMO was 
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used as a fluorescence background control. Briefly, 1 × 105 cells 
were incubated in the dark/room temperature for 30 min in the 
presence of antibodies at concentrations recommended by the 
manufacturers. We used FACS Lysing solution (BD Biosciences) 
for red cells lysing after staining of whole blood. Cells were then 
washed with buffered solution and at least 10,000 events were 
acquired using FACS LSRII FORTESSA (BD Biosciences).
Data were analyzed using the FACSDIVA (BD Biosciences) 
and/or the FlowJo software (Tree Star, Ashland, OR, USA). 
The gating strategy is described in Figure S2 in Supplementary 
Material.
elisa
The FRCs and DNCs were cultured with or without inflam-
matory stimuli provided by either TNFα (25  ng/mL) in 
combination with IL-1β (5 ng/mL) treatment or IFN-γ (50 ng/
mL) treatment (21, 22). The culture supernatant was removed 
24  h after treatment and frozen for ELISA assays. The cells 
that remained attached to the culture plate were harvested 
for RNA extraction (see RNA Extraction). We used ELISA 
Duo set (R&D Systems) for quantification of CCL2, CCL19, 
and CCL20, Quantikine (R&D Systems) for IL7 and CXCL12 
quantification. For IL-6, IL-8, and IL-10, we used reagents 
from Immunotools (Immunotools, Germany). All procedures 
followed the manufacturers’ instructions. Plate readings 
were carried out using the microplate reader SpectraMax® 
i3 (Molecular Devices, Sunnyvale, CA, USA). Readings were 
performed at 450/540  nm and the standard curve was set at 
4 parameters logistic or log/log curve fit, according to each 
manufacturer’s protocol.
Migration assay
The FRCs and DNCs were cultured with or without inflammatory 
stimuli provided by either IFN-γ (50 ng/mL) or TNF-α (25 ng/
mL) in combination with IL-1β (5 ng/mL) treatments. Monocyte-
derived iDCs were stained with 5 µM/mL of carboxyfluorescein 
succinimidyl-ester (CFSE-Invitrogen) for detection using green 
fluorescence, as previously described (23). The iDCs (2 ×  104 
cells) were placed in 3.0  µm transwell inserts (Anopore mem-
branes, Nunc Kamstrup, Denmark) within chambers in 24-well 
plates containing FRCs or DNCs previously treated for 24  h 
with inflammatory signals, or in plates with untreated FRCs and 
DNCs. After 24 h in culture, the insert was removed from the 
culture plate and cells resting in the upper part of the insert (lose 
cells) were removed. The filter was removed from the chambers 
and the fluorescent cells trapped in the transwell were counted 
using a fluorescence microscope (Olympus IX51).
Aiming to evaluate the impact of CCL2 and CCL20 on den-
dritic cells migration, iDCs (2 × 103 cells) were placed on 8.0 µm 
transwell inserts within chambers (Translucent Membranes, 
Greiner Bio-One, Vienna, Austria) in 24-well plates containing 
either FRCs or DNCs previously treated or untreated for 24  h 
with inflammatory signals. Cells were treated with neutralizing 
antibodies for CCL2 (2  µg/mL) or CCL20 (5  µg/mL) (ELISA 
capture antibodies, R&D Systems). After 24  h, the insert was 
removed from the culture plate and the cells that transmigrated 
toward FRCs or DNCs were visualized in the lower part of the 
chamber and counted using the detection of green fluorescence 
by a fluorescence microscopy (Olympus IX51).
rna extraction
RNA extraction was carried out using RNAeasy Kit (Qiagen, 
Valencia, CA, USA) according to the manufacturer’s instruc-
tions. For RNA quantification and quality analysis, we used the 
NanoVue spectrophotometer (GE Healthcare Life Sciences, Little 
Chalfont, UK).
gene expression analysis Using Dna 
Microarrays
To understand patterns of cytokine and chemokine gene 
expression by FRCs and DNCs, we used DNA microarrays. We 
compared FRCs and DNCs that were treated or not with IFN-γ 
(50  ng/mL) or TNF-α (25  ng/mL) in combination with IL-1β 
(5  ng/mL). Cells from four LNs were used for this assay: two 
LNs isolated from cancer patients (LN04 and LN15), one from 
a diverticulitis patient (LN12), and one isolated from a healthy 
liver donor (LN16). Gene expression levels were evaluated using 
the DNA microarray SurePrint G3 Human Gene Expression 
8 × 60K v2 Microarray Kit (Agilent Technologies, USA). Labeling 
of probes with cyanine 3 dye (Cy3), hybridization, and washing 
procedures strictly followed the manufacturer’s protocol (One 
Color Quick Amp Labeling Kit, Agilent Technologies). The arrays 
were scanned using a SureScan Microarray Scanner (Agilent 
Technologies, USA) using default parameters for Agilent micro-
arrays. Initial data processing was performed using the Agilent 
Feature Extraction software (version 10.5), and GeneSpring 
(Agilent Technologies, USA) was used for data normalization 
(quantile normalization) and transformation. For the differential 
gene expression analysis, the gene-level normalized intensities 
were compared between sample pairs and a fold-change was cal-
culated for each cell type per LN (treated vs untreated cells). The 
expression data are deposited at the Gene Expression Omnibus 
site (accession number GSE89612 associated with platform 
GPL16699).
statistical analysis
The statistical analysis was performed using the GraphPad Prism 
program (version 6.02). The Student’s t-test was used for com-
parison between two groups or ANOVA for multiple compari-
sons with Bonferroni correction, when necessary. A minimum 
p < 0.05 significance was considered for all experiments.
resUlTs
Pathological analysis of lns evidentiate 
Tissue integrity
The pathological analysis showed tissue integrity and absence of 
metastasis in the cancer-derived LNs. LNs were also evaluated for 
cells distribution using histochemistry markers for CD3, CD20, 
and CD68 (24) and, accordingly, we observed that T lymphocytes 
were present in the paracortex region, B lymphocytes were within 
the follicles, and the macrophages were distributed throughout 
the LN. We observed that follicles in cancer-derived LNs were not 
FigUre 1 | Phenotypic profile and cell sorting of stromal cells isolated from human lymph nodes (lns). Stromal cells isolated from human LNs (four 
samples) were analyzed by flow cytometry for: (a) size vs granularity and fluorescence minus one (FMO) for gp38 (FMO vs CD31), histograms of gated cells show 
unlabeled cells (black line) and stained cells (red line), (B) LN stromal cells were phenotyped in fibroblastic reticular cells (FRCs) or double-negative cells (DNCs) by 
gp38 and blood endothelial cells, lymphatic endothelial cells, and follicular dendritic cells were excluded due to absence of CD31, CD35, CD106, and HLA-DR 
expression, (c) FRCs and DNCs showed positivity for CD29, CD44, CD73, CD90, CD105 and no expression of CD14, CD34, CD45, indicating absence of 
hematopoietic cells, (D) flow cytometry data showing purity over 97% in the cell sorting of (e) FRCs and (F) DNCs. All four LNs were fully characterized; this figure 
displays the results from LN12.
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as well delimited as those obtained from the healthy liver donor or 
from the diverticulitis patient (Figures S3A–C in Supplementary 
Material).
cell subpopulations isolated from lns 
Were classified as stromal cells
Cells isolated from the human LNs and used in this study 
were uniform in size and granularity (FSC vs SSC). They did 
not express markers for endothelial cells (CD31 and CD106), 
and the absence of CD35 expression indicated the absence of 
FDCs among them (Figures  1A,B). These cells also did not 
express hematopoietic markers such as CD14, CD34, CD45, 
or HLA-DR, they expressed CD29, CD44, CD73, CD90, 
and CD105 (Figure  1C) and were classified into FRCs and 
DNCs subpopulations according to PDPN/gp38 expression 
(Figures  1D–F). They displayed fibroblastic shape and were 
plastic adherent (Figures 2A–O). FRCs and DNCs were able to 
differentiate into osteocyte-, chondrocyte-, and adipocyte-like 
cells (Figures 3A–F). Thus, we concluded that, as expected, the 
human FRCs and DNCs displayed stromal cells characteristics 
that fulfill the international phenotypic criteria determined by 
International Society for Cellular Therapy (19).
FigUre 2 | continued
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cytokine and chemokine expression Was 
induced by inflammatory Factors
Microarray gene expression analysis was used to evaluate the 
expression of interleukins and chemokines and respective recep-
tors directly involved in immune cells activation and migration 
following inflammatory stimuli. We hypothesized that DNCs 
and FRCs are cell subpopulations that may respond differently 
to such conditions. We compared results from standard culture 
conditions and cells submitted to 24  h treatment with either 
IFN-γ or TNF-α + IL-β. A summary of the results is displayed in 
Table 1, and complete data reports are displayed in Tables S1–S4 
in Supplementary Material.
After IFN-γ treatment, we observed upregulation of chemokine 
genes expression in both FRCs and DNCs, but with marked 
differences (Table  1). CCL5 and CXCL2 were more expressed 
in DNCs than in FRCs, while CCL2, CCL8, CCL13, CXCL3, 
FigUre 2 | continued
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CXCL8, CXCL9, CXCL10, and CXCL11 were more expressed 
in FRCs (Table 1). Alterations in the expression levels were also 
observed after TNF-α + IL-1β treatment, with chemokines being 
more expressed in treated FRCs when compared to DNCs, and a 
group of chemokines upregulated only in treated FRCs (CCL3L3, 
CXCL2, and CXCL11).
To confirm that the differential patterns of chemokines and 
interleukins expression following treatment was dependent upon 
the cell type, CCL2, CCL20, CXCL8, and CXCL12 protein levels 
were evaluated in the culture medium using ELISA. TNFα + IL-1β 
stimulation of FRCs and DNCs significantly enhanced CCL2 
secretion (26,050 ± 12,608 and 12,677 ± 2,178 pg/mL, respec-
tively) when compared to the correspondent IFN-γ treatment 
(3,668  ±  524 and 2,390  ±  1,262  pg/mL) or correspondent 
untreated cells (913 ± 280 and 587 ± 141 pg/mL), corroborat-
ing the gene expression results (Figure  4A). Similarly, CCL20 
FigUre 2 | confocal microscopy. Confocal microscopy revealing the morphology of fibroblastic reticular cells (FRCs) isolated and expanded in vitro: (a) 
intracellular gp38/PDPN staining (red), (B) actin microfilament stained with tubulin (green), (c) nuclei detection with DAPI (blue), (D) merge (red, green and blue), 
(e,K) cell membrane staining with gp38/PDPN (red), (h) control (secondary antibody only) displaying absence of unspecific staining in red, (F,i,l) nuclei detection 
with DAPI (blue), (g,J,M,n,O) merge (red and blue), (M,n,O) images of mixed culture with FRCs and double-negative cells.
8
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secretion in FRCs culture was also significantly enhanced after 
TNFα + IL-1β stimulation (610 ± 176 pg/mL) when compared 
to IFN-γ (13 ±  2  pg/mL) or untreated cells (14 ±  3  pg/mL) 
(Figure  4B). There was a moderate secretion of CXCL12 in 
untreated DNCs (44 ± 33 pg/mL) and in FRCs (67 ± 81 pg/mL), 
which was not altered by inflammatory stimulation (Figure 4C), 
while CCL19 was undetectable in every condition.
IL-6 secretion was significantly enhanced in DNCs after 
TNFα + IL-1β stimulation (54.8 ± 15.2 pg/mL) when compared 
to IFN-γ (10.7 ± 1.2 pg/mL) and untreated cells (7.6 ± 0.9 pg/
mL) (Figure 4D), but there were no significant differences in IL-6 
secretion by FRCs (Figure 4D). However, we observed a variation 
in the expression levels of IL-6 among FRC samples and a rela-
tively high secretion of IL-6 by untreated FRCs (18.21 ± 13 pg/
mL) or IFN-γ stimulated FRCs (21.42 ± 12 pg/mL).
Enhanced IL-7 secretion by FRCs was observed after 
TNFα +  IL-1β stimulation (5.7 ±  1.0  pg/mL) when compared 
to untreated cells (2.7 ±  0.7  pg/mL), but no differences were 
observed in DNCs (Figure 4E).
CXCL8 (IL-8) secretion was significantly enhanced in FRCs and 
DNCs after TNFα + IL-1β stimuli (78.4 ± 2.6 and 73.5 ± 2.5 pg/
mL, respectively) compared to their respective untreated controls 
(10.2 ± 4.9 and 4.4 ± 0.4 pg/mL), while IFN-γ did not alter this 
secretion significantly (Figure 4F). IL-10 secretion by FRCs or 
DNCs was almost undetectable under standard and inflamma-
tory conditions (Figure 4G).
Our results suggest that the chemokine and cytokine expres-
sion of these subpopulations in the LN microenvironment may 
be important to guarantee homeostasis, which is modified 
under inflammatory conditions, possibly leading to specific 
responses.
chemokine receptors expressed by 
Monocytes, Dendritic cells, and 
lymphocytes suggest Differential 
interaction between Frcs, Dncs, and 
immune cells
Fibroblastic reticular cells and DNCs presented different expres-
sion levels of cytokines and chemokines upon inflammatory 
stimulation. In order to verify whether these expression patterns 
could lead to a differential interaction with immune cell popula-
tions, we evaluated the expression of chemokine receptors in 
lymphocytes, monocytes, and monocyte-derived DCs. CCR2 
was highly expressed in monocytes and DCs, both immature and 
mature. There were variations in CCR6 and CXCR4 expression 
and increased expression of CCR3, CCR5, and CCR7 according 
to the maturation status of the DCs (Figures 5A–F). Regarding 
lymphocytes, we observed that there were subpopulations 
expressing all the chemokine receptors evaluated in this study. 
In addition to those receptors, lymphocytes isolated from LNs 
expressed higher CXCR4 levels compared to peripheral blood 
TaBle 1 | gene expression of chemokines and interleukins in double-
negative cells (Dncs) and fibroblastic reticular cells (Frcs) following 
treatment with iFn-γ or TnF-α + il-1β.
chemokines and 
interleukins induced 
by iFn-γ
chemokines and 
interleukins induced 
by TnF-α + il-1β
gene Dnc Frc Dnc Frc
CCL2 12.65 937.80 26.74 3,097.21
CCL3 – – 58.92 158.58
CCL5 15.93 – 99.25 53.83
CCL7 30.26 25.98 38.53 38.12
CCL8 109.60 398.84 43.45 –
CCL11 – – – 6.48
CCL13 72.59 141.17 – 7.83
CCL20 – – – 259.11
CXCL1 – – 667.98 1,769.66
CXCL2 51.94 – 465.36 233.16
CXCL3 – 10.41 1,015.14 1,531.52
CXCL5 – – – 38.23
CXCL6 – – – 779.07
CXCL8 – 58.90 2,141.93 4,932.57
CXCL9 – 1,064.60 – –
CXCL10 191.19 491.06 122.44 11.78
CXCL11 174.2 247.68 – –
CCL3L3 – – – 10.01
IL-1α – – – 127.54
IL-1β – – 579.39 1,023.30
IL-4I1 8.07 – 19.61 –
IL-6 – – 26.28 219.28
IL-11 – – – 352.47
IL-15 – 334.28 – 29.85
IL-32 13.23 – 10.34 5.61
IL-33 6.26 20.37 22.45 189.35
IL-36γ – – 11.87 28.78
IL-18 binding protein – 168.29 – –
IL-1RN – – 14.71 405.44
IL-3RA 7.20 – – –
IL-7R – – – 159.50
IL15RA 6.67 8.32 3.49 –
Results represent the average fold-change between treated cells vs controls in four 
lymph nodes (LNs) and absent results indicate that uniform upregulation (fold-
change > 2.0) was not observed in all four LNs. The DNCs and FRCs used in this 
experiment were derived from LN04, LN12, LN15, and LN16. Individual data of each 
LN was included in Tables S1–S4 in Supplementary Material.
FigUre 3 | Fibroblastic reticular cells (Frcs) and double-negative 
cells (Dncs) differentiation into three lineages. FRCs and DNCs were 
separated by cell sorting for differentiation: (a–c) FRCs and, (D–F) DNCs; 
(a,D) FRCs and DNCs staining with toluidine blue showing formation of 
proteoglycans matrix on chondrocyte differentiation, (B,e) FRC and DNC 
displaying formation of cytoplasm lipid droplets, stained with oil red, 
indicating adipocyte differentiation, (c,F) FRCs and DNCs staining with 
Alizarin red indicates the formation of calcium matrix during osteocyte 
differentiation. Images at original magnification of 20×. All four LN were fully 
characterized (this figure displays the results from LN12).
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samples (Figures 6A–C). The chemokine receptors analyzed sug-
gest that the interaction between FRCs and DNCs and immune 
cells may differ. For instance, we observed an intense upregulation 
of CCL2 and CCL20 genes and secretion by FRC when compared 
to DNCs and their respective receptors, CCR2 and CCR6, are 
expressed in iDCs.
Monocyte-Derived Dendritic cells Migrate 
toward TnF-α + il-1β-Treated Frcs
The effect of inflammatory stimulation of FRCs and DNCs on 
immune cell migration was evaluated by a migration assay using 
iDCs. We used monocyte-derived DCs and not LN isolated cells, 
due to the limited number of conventional DCs within LNs and/
or circulating in peripheral blood (25). We found a more intense 
migration of iDCs toward TNF-α +  IL-1β-treated FRCs, less 
migration toward similarly treated DNCs, and lower migration 
rates toward the untreated cells (Figures 7A–F). iDCs migration 
toward IFN-γ-treated FRCs or DNCs was low and similar to the 
controls (Figure 7G).
Since iDCs expressed CCR2 and CCR6 receptors and 
migrated toward TNF-α + IL-1β-treated FRCs that expressed and 
secreted high levels of CCL2 and CCL20, we used neutralizing 
antibodies for these chemokines to confirm their involvement 
FigUre 4 | chemokine secretion by fibroblastic reticular cells (Frcs) and double-negative cells in homeostasis and under inflammatory stimuli. 
Lymph node stromal cells (derived from LN04, LN12, LN15, and LN16) cultured during 7 days and treated with TNFα + IL-1β (light gray bar) or IFN-γ (dark gray bar) 
for 24 h. White bars correspond to cells cultured without treatment. Chemokines and cytokines were measured in each cells supernatant and results presented are 
the average and standard deviation, (a) CCL2, (B) CCL-20, (c) CXCL-12, (D) IL-6, (e) FRCs IL-7 [IL-7 assay range for cell culture supernatant should be between 
0.2 and 10 pg/mL (sensitivity level is 0.1 pg/mL)], (F) IL-8/CXCL-8, (g) IL-10 secretion was lower than 0.1 pg/mL and was not altered by cytokines stimulation 
(*p < 0.05, ***p < 0.001).
10
Severino et al. Human Lymph Node-Derived Fibroblastic Cells
Frontiers in Immunology | www.frontiersin.org February 2017 | Volume 8 | Article 141
in iDCs migration (Figures  7H–I). Our results showed that 
iDCs migration toward TNF-α  +  IL-1β stimulated FRCs or 
DNCs treated independently with anti-CCL2 or anti-CCL20 was 
reduced compared to the treated controls. However, these results 
were statistically significant only for FRCs, thus confirming the 
participation of FRCs in iDCs recruitment through CCR2/CCL2 
and CCR6/CCL20 activation.
DiscUssiOn
Stromal cells were first identified and characterized in murine 
LNs as structural cells (5, 26, 27). Recently, reports indicate 
that these cell populations are directly involved in the immune 
response initiation and regulation (16, 27). However, to our 
knowledge, there are only three recent articles that evaluated 
FigUre 5 | continued
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the potential immune functions of stromal cells from human 
LNs (10, 28, 29). None of these studies performed extensive 
in vitro studies with different stimulation as we described in this 
manuscript.
In one of these studies (10), the authors isolated and compared 
human dermal fibroblasts with LN reticular fibroblastic cells 
gene expression after treatment with TNF-α, IL-4, IL-6, and 
IL-13. However, in their study, there was no distinction between 
FRCs and DNCs subsets. A second study compared the differ-
ences in gene expression between FRCs isolated from murine 
skin draining LNs and mesenteric LNs in steady state. However, 
they only described in detail the successful isolation and culture 
methods of human FRCs (28). The third study evaluated the role 
of stromal cells from tonsils and bone marrow on B cells derived 
from follicular lymphoma, but there was no distinction between 
FRCs and DNCs subsets (29). In contrast, our study characterized 
plastic adherent cells derived from human LNs as stromal cells 
according to their phenotype and their ability to differentiate in 
three mesodermal lineage cells and we distinguished FRCs and 
DNCs among adherent cells based on gp38/PDPN and CD31 
expression.
Literature reports show that murine FRCs and DNCs respond 
to inflammatory stimuli by expressing several molecules involved 
in the immune response (9–12). We chose to use IFN-γ and TNF-
α +  IL-1β as inflammatory stimuli based on their specific but 
also diverse mechanisms of inducing immune cell response (17, 
18, 30).
Our results show that upon stimulation with either IFN-γ or 
TNF-α + IL-1β, the population of DNCs and FRCs derived from 
human LNs upregulated chemokines gene expression and protein 
levels. However, there were differences between treatments and 
cell subpopulation. For instance, CCL2 and CCL20 secretion was 
significantly increased in FRCs in response to TNF-α +  IL-1β 
stimulation when compared to IFN-γ treatment, untreated 
FigUre 5 | chemokine receptors on monocytes from peripheral blood and monocyte-derived Dcs. (a) Monocytes were isolated by positive selection 
(CD14) and cultured for 7 days with IL-4 (20 ng/mL) and GM-CSF (50 ng/mL) to differentiate into, (B) immature and, (c) mature dendritic cells when stimulated with 
LPS (100 ng/mL); each cellular subset was evaluated for CCR2, CCR3, CCR5, CCR6, CCR7, and CXCR4 expression by flow cytometry and the frequency of 
positive cells to chemokine receptors was plotted in the corresponding graphs to (D) monocytes, (e) immature and, (F) mature dendritic cells. Results are 
expressed in percentage and median of fluorescence intensity (MFI). Peripheral blood was collected from four healthy individuals for this assay.
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controls or similarly treated DNCs, corroborating the higher gene 
upregulation in FRCs compared to DNCs.
CCL2, also known as monocyte chemoattractant protein-1, 
is involved in chemotaxis of CCR2-expressing memory T cells, 
monocytes, and DCs to sites of inflammation produced by either 
tissue injury or infection. CCL20 also known as macrophage 
inflammatory protein-3 α (MIP-3α) is implicated in lymphoid 
tissue function by recruiting either lymphocytes or dendritic 
cells through CCR6. Our findings corroborate a previous 
report by Vega et al., which also described an enhancement of 
CCL2 gene expression in human TNF-α-treated FRCs (10). In 
contrast, Malhotra et al. reported unaltered expression of CCL2 
or CCL20 in mice-derived FRCs and DNCs after LPS in  vivo 
stimulation (8).
We observed a more intense migration of monocyte-derived 
DCs toward TNF-α +  IL-1β-treated FRCs. Monocyte-derived 
DCs expressed CCR2, CCR5, and CCR6 receptors, which are 
counterparts of CCL2, CCL5, CCL13, and CCL20, genes that 
were upregulated in treated FRCs. Despite the fact that around 
90% of iDCs expressed CCR2 and only around 25% expressed 
CCR6, both receptors seem to play a role in recruiting iDCs 
since the independent neutralization of CCL2 or CCL20, their 
respective ligands, reduced migration toward TNF-α +  IL-1β-
treated FRCs. There are reports showing that CCR6 varies 
between individuals and that monocyte-derived iDCs expressing 
CCR6 are responsive to CCL20 (31, 32). This result confirmed 
the participation of FRCs in iDCs recruitment through the axis 
CCR2/CCL2 and CCR6/CCL20. In agreement, a report that 
correlates chemokines and DCs in sites of oral inflammation, 
verified that the expression of CCL2 and CCL20 was positively 
correlated with increased densities of immature CD1a (+) 
dendritic cells (33). In agreement with our observations, a study 
using monocyte-derived macrophages also demonstrated a role 
of the CCR2/CCL2 axis in the migration of these cells (34). The 
study further demonstrates a role for CCL2 in other leukocytes 
functions besides chemotaxis (34).
Studies using murine models reported CCL19 secretion by 
freshly isolated FRCs, both at resting state and after inflamma-
tory stimuli (8, 12), as well as low levels of CCL19 and CCL21 
transcripts from cultured FRCs (35). In contrast, our results 
did not detect altered gene expression of CCL19 or CCL21, 
and we were not able to detect secretion of CCL19 by resting 
human FRCs and DNCs or following inflammatory stimuli. 
Our results are in agreement with Vega et al., who, after TNF 
treatment, did not detect gene expression of CCL19 or CCL21 
by FRCs (10).
CXCL12 via CXCR4 is involved in naïve T cell and DCs entry 
in the LN (14). Our results showed a high expression of CXCR4 
in LN-derived lymphocytes. We also showed that CXCL12 secre-
tion was present in FRCs and DNCs cultures. However, CXCL12 
FigUre 6 | chemokine receptors in lymphocytes. Lymphocytes derived from: (a) peripheral blood of healthy volunteers (n = 11) and (B) lymphocytes derived 
from lymph node (LN) (n = 06, LN04—larynx cancer; LN08, LN16, and LN24—liver donors; LN12—diverticulitis; LN15—breast cancer) were evaluated for CCR2, 
CCR3, CCR5, CCR6, CCR7, and CXCR4 expression by flow cytometry. Results are expressed in percentage and median of fluorescence intensity (MFI), (c) 
Comparative graphs for CXCR4 expression between peripheral and LN lymphocytes (p < 0.001).
13
Severino et al. Human Lymph Node-Derived Fibroblastic Cells
Frontiers in Immunology | www.frontiersin.org February 2017 | Volume 8 | Article 141
secretion was not altered following inflammatory stimuli, cor-
roborating previous reports (8, 36).
Literature reports that FRCs can secrete interleukins (5, 10). 
Indeed, FRCs, but also DNCs, stimulated with IFN-γ or TNF-
α +  IL-1β presented altered cytokine expression. Differences 
in the expression patterns were observed. For instance, FRCs 
and DNCs treated with TNF-α + IL-1β upregulated IL-6 gene 
expression, while IL-6-enhanced secretion was only significant 
for DNCs. In contrast, after IFN-γ treatment, there was IL-6 
gene expression upregulation in DNCs but no significant 
alteration in protein secretion. A previous study described the 
upregulation of IL-6 transcripts in FRCs after TNF-α treatment 
(10). IL-6 is a cytokine that plays a role on CD4 T lymphocyte 
differentiation favoring a Th17 profile (37). FRCs and DNCs 
treated with TNF-α +  IL-1β also displayed a clear upregula-
tion of IL-8 (CXCL8) gene expression and protein secretion. 
However, IL-8 was overexpressed in FRCs after IFN-γ treat-
ment, while IL-8 protein secretion remained unaltered (14). 
Corroborating our findings, a lymphoma study also reported 
upregulation of IL-8 in FRCs after TNF-α treatment (10). IL-8 
plays a role as neutrophils chemoattractant, but since there 
are no neutrophils in LNs, this chemokine could be related 
to T cells in this microenvironment. Hess et  al. reported an 
unexpected finding of CXCR1 (IL-8 receptor) on a CD8 T cell 
subset with high cytotoxic potential and terminally differenti-
ated (38).
IL-4I1 was upregulated only in DNCs following TNF-
α + IL-1β treatment, while IL7-R was upregulated only in FRCs. 
IL-7R expression has been described in stromal cells of secondary 
lymphoid organs and studies reported that IL-7 signaling through 
IL-7R modulates IL-7 production, consequently playing a role on 
T cell homeostasis (15, 39). We also observed low levels of IL-7 
gene expression (Tables S1–S4 in Supplementary Material) and 
secretion by FRCs, which were enhanced after treatment with 
IFN-γ or TNF-α + IL-1β.
IL-10 is an anti-inflammatory cytokine that participates of 
Th1, NK cells, and macrophages inhibition during infection 
(40). Like other studies, we did not detect IL-10 expression or 
secretion by DNCs or FCRs under steady state or after inflam-
matory stimuli (6, 8, 26). However, IFN-γ treatment enhanced 
IL-18 binding protein (IL-18BP) in FRCs. IL-18BP is synthetized 
mainly by mononuclear cells and binds to IL-18 impairing their 
ligation with the receptor, downregulating the Th1 profile (41). 
IL-4-induced gene 1 (IL4I1) is only upregulated in DNCs by both 
FigUre 7 | continued
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treatments and contributed to T cell receptor unresponsiveness in 
human T helper 17 cells (42).
Most chemokines and cytokines upregulated in FRCs and 
DNCs after IFN-γ or TNF-α + IL-1β stimuli may be described 
as pro-inflammatory, and few have been described as hemostatic 
or with dual function (43). This result suggests that these cells 
respond accordingly to the inflammatory stimulus received and 
that they participate of the immune response by recruiting and 
FigUre 7 | Migration assay for immature dendritic cells (iDcs). Confluent double-negative cells (DNCs) or fibroblastic reticular cells (FRCs) were treated with 
IFN-γ (50 ng/mL) or TNF-α (25 ng/mL) + IL-1β (5 ng/mL) for 24 h. CFSE-labeled monocyte-derived iDCs were added into the upper chamber of the transwell in the 
absence or presence of neutralizing antibodies [CCL2 (2 µg/mL) or CCL20 (5 µg/mL)]. iDCs stained trapped in the transwell or that transmigrated were visualized by 
CFSE staining (green). (a) Control DNCs, (B) control FRCs; iDCs that migrated toward INF-γ treated (green), (c) DNCs or (D) FRCs; iDCs that migrated toward 
TNF-α + IL-1β treated (green) (e) DNCs or (F) FRCs, (g) quantification of iDCs trapped in the transwell membrane, (h) quantification of iDCs that transmigrated 
toward DNCs controls and treated with CCL2 and CCL20 neutralizing antibodies, (i) quantification of iDCs that transmigrate toward FRCs controls and treated with 
CCL2 and CCL20 neutralizing antibodies. The LN04 and LN16 were used for this assay (n = 3).
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stimulating immune cells after initial signals of inflammation/
infection.
The diversity of interleukins and chemokines secreted by FRCs 
and DNCs indicate specific signaling and recruitment of these 
lymphocytes subsets and DCs. This effect should depend on the 
inflammatory environment. Taken together, our results suggest 
that DNCs and FRCs play an important role in the recruitment of 
immune cells to secondary lymphoid organs, including DC and 
T cells migration. Further, we have confirmed an important par-
ticipation of FRCs in DCs recruitment through the axis CCR2/
CCL2 and CCR6/CCL20.
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FigUre s1 | Double-negative cell (Dnc) and fibroblastic reticular cell 
(Frc) sorting purity. (a) Stromal cells isolated from lymph nodes were sorted 
in two populations, (B,c) DNCs and, (D–F) FRCs according to gp38/PDPN 
expression. After DNCs and FRCs expansion in culture and before each 
experiment, gp38/PDPN expression was verified, and when purity was lower 
than 95%, (e,F) cells were resorted.
FigUre s2 | gate strategy for monocytes, dendritic cells, and 
lymphocytes. (a) Monocytes were gated on FSC vs CD14, followed by CD14 
vs CD33, and the double-positive cells were analyzed for CD80, CD86, CD209, 
and HLA-DR, (B) immature and, (c) mature dendritic cells were gated on FSC vs 
CD14, followed by CD14 vs CD33, and the CD14-CD33 + positive cells were 
analyzed for CD80, CD86, CD209, and HLA-DR, (D) Lymphocytes were gated 
on FSC vs CD3, and the CD3 cells were gated for CD4 and CD8, and CD3, 
CD3CD4, or CD3CD8 positive cells were analyzed for chemokine receptors, 
expression here illustrated by CCR6.
FigUre s3 | histopathology of human lymph nodes (lns). (a) LN derived 
from larynx cancer patient LN04, (B) LNs derived from liver donor LN16. (c) LN 
derived from diverticulitis LN12 hematoxylin–eosin (HE) immunostaining show the 
organ integrity LN immunohistochemistry for CD3, CD20, or CD68 show the 
presence of T lymphocytes (CD3), B lymphocytes (CD20), and macrophages 
(CD68), respectively (magnification of 10×).
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